Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,091.20
+13.50 (1.25%)
Jun 1, 2026, 3:30 PM IST
Zydus Lifesciences Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Zydus Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹1,067. The average 1-year stock price forecast is 2.26% lower than the current stock price, while the lowest is ₹800.00 (-26.69%) and the highest is ₹1,457 (+33.52%).
Price Target: ₹1,067 (-2.26%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Zydus Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 5 | 4 | 6 |
| Buy | 8 | 8 | 8 | 8 | 8 | 9 |
| Hold | 10 | 10 | 9 | 10 | 10 | 10 |
| Sell | 4 | 4 | 4 | 4 | 4 | 2 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 30 | 30 | 30 | 30 | 29 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Maintains ₹1,050 | Hold | Maintains | ₹1,050 | -3.78% | May 22, 2026 |
Unknown Analyst Prabhudas Lilladher No rating | Prabhudas Lilladher | Buy Maintains ₹1,020 | Buy | Maintains | ₹1,020 | -6.52% | Feb 12, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.